JamesWLynchJr.MD

PubMed

• 54 citations
  Involved-node proton therapy in combined modality therapy for Hodgkin lymphoma: results of a phase 2 study.
  Bradford S. Hoppe, Stella Flampouri, Robert Zaiden, William B. Slayton, Eric Sandler
  International Journal of Radiation Oncology, Biology, Physics. 2014-08-01
• 33 citations
  Paraneoplastic manifestations of lymphoma.
  Karl T. Hagler, James W. Lynch
  Clinical Lymphoma. 2004-06-01
• 223 citations
  BCL2 Expression Is a Prognostic Marker for the Activated B-Cell–Like Type of Diffuse Large B-Cell Lymphoma
  Javeed Iqbal, Vishala Neppalli, George E. Wright, Bhavana J. Dave, Douglas E. Horsman
  Journal of Clinical Oncology. 2006-02-20

Journal Articles

• What Makes a Medical School Great?  
  Gunderman RB and Lynch JW, The Atlantic, 3/28/2013
• Improving the therapeutic ratio in Hodgkin lymphoma through the use of proton therapy.  
  Hoppe BS, Flampouri S, Lynch J, Slayton W, Zaiden R, Li Z, Mendenhall NP, Oncology (Williston Park), 5/1/2012
• Consolidative involved-node proton therapy for Stage IA-IIIB mediastinal Hodgkin lymphoma: preliminary dosimetric outcomes from a Phase II study.  
  Hoppe BS, Flampouri S, Su Z, Morris CG, Latif N, Dang NH, Lynch J, Li Z, Mendenhall NP, Int J Radiat Oncol Biol Phys (Epub 2011 Oct 17), 5/1/2012
• Effective Dose Reduction to Cardiac Structures Using Protons Compared with 3DCRT and IMRT in Mediastinal Hodgkin Lymphoma.  
  Hoppe BS, Flampouri S, Su Z, Latif N, Dang NH, Lynch J, Joyce M, Sandler E, Li Z, Mendenhall NP, Int J Radiat Oncol Biol Phys [Epub ahead of print], 3/2/2012
• Outcomes in patient with NHL treated with Bexxar with or without external-beam radiotherapy.  
  Smith K, Byer G, Morris C, Kirwan J, Lightsey J, Mendenhall N, Hoppe B, Lynch J, Olivier K, Int J Radiat Oncol Biol Phys, 5/11/2011
• Managing cetuximab hypersensitivity-infusion reactions: incidence, risk factors, prevention, and retreatment.  
  George TJ Jr, Laplant KD, Walden EO, Davis AB, Riggs CE, Close JL, George SN, Lynch JW, J Support Oncol, 3/1/2010
• Information Overload and the Need for Wisdom: A Medical Perspective  
  James W Lynch MD, Reconsiderations, 12/1/2009
• Long-term outcomes for stage I-II aggressive non-Hodgkin’s lymphoma of Waldeyer’s ring  
  Daniel T. Chang, MD; Nancy P. Mendenhall, MD; James W. Lynch, MD; Christopher G. Morris, MS; Kenneth R. Olivier, MD, Am J Clin Oncol, 6/1/2009
• Clinical Presentation and Outcomes of Lymphocyte-predominant Hodgkin’s Disease at the University of Florida  
  Chera B, Olivier K, Morris C, Lynch J, Mendenhall M, Am J Clin Oncol, 12/1/2007
• Discordant Expression of CD20 by Flow Cytometry and Immunohistochemistry in a Patient Responding to Rituximab: An Unusual Mechanism.  
  Walsh K, Lynch JW, Al-Quran S, Li Y and Braylan R, Clin Lymphoma Myeloma, 1/1/2007
• Lethal Midline Granuloma  
  Mendenall, W, Olivier K, Lynch J, Mendenhall N, America J of Clinical Oncology, 4/1/2006
• Potential Influence of Health Systems in Accrual to Clinical Trials in Lymphoma.  
  Hagler K and Lynch JW, J Clin Oncol, 10/1/2005
• Oncology Board Review Study Guide  
  Lynch JW, The American Journal of Oncology Review, 4/1/2005
• A Phase II Trial of Gemcitabine in Low Grade NHL  
  Bradley J.G. Larson MD, John M. Waples MD, Annette Pusateri RN, Nancy P. Mendenhall MD, and James W. Lynch Jr. MD FACP., A Phase II Trial of Gemcitabine in Low Grade NHL, 4/1/2005
• Phase II Trial of Individualized Pharmacokinetic Dosing of Rituximab Maintenance for Patients with CD-20 Positive Lymphoproliferative Disorders.  
  Lucio Gordan, William B. Grow, Raul C. Braylan, Nancy P. Mendenhall, Vonda Douglas, Annette Pusateri, Lakshmi Balasubramanian, James W. Lynch, J Clin Oncol, 2/1/2005
• Paraneoplastic Syndromes in NHL and HD  
  Hagler K and Lynch JW, Clinical Lymphoma, 6/1/2004
• Management Of Neurotropic Low-Grade B-Cell Lymphoma: Report Of Two Cases.  
  Garcia-Serra A, Mendenhall N, Hinerman R, Lynch, J, Braylan R and Mancuso A, Head and Neck, 11/1/2003
• Diagnosis and Management of Cancer Metastatic to the Skeleton.  
  Grow WB, Marsh R, Lynch JW, Emergency Medicine, 2/1/2003
• Regaining Compassion  
  Lynch JW, House Calls; Journal of the Alachua County Medical Society Fall 2003, 1/1/2003
• Poor Mobilization of Peripheral Blood Stem Cells is a Risk Factor for Worse Outcome in Lymphoma Patients Undergoing Autologous Stem Cell Transplantation.  
  Gordan LN, Sugrue MW, Lynch JW, Williams KD, Khan SA, Wingard JR and Moreb JS, Leukemia & Lymphoma, 1/1/2003
• Correlation of early lymphocyte recovery and progression-free survival after autologous stem-cell transplant in patients with Hodgkin’s and non-Hodgkin’s Lymphoma.  
  Gordan LN, Sugrue MW, Lynch JW, Williams KD, Khan SA, Wingard JR, Moreb JS, Bone Marrow Transplantation, 1/1/2003
• A Phase II Study of Fludarabine Combined with Interferon alpha-2a in Patients with Low Grade Non-Hodgkin’s Lymphoma.  
  Lynch JW, Hei DL, Braylan RC, Rimsza L, Staab EV, Bewsher C, Mendenhall NP, Hudson JK, American Journal of Clinical Oncology, 8/1/2002
• Natural killer-like T-cell lymphoma of the patotoid in an HIV-infected patient. Archives of Pathology and Laboratory Medicine  
  Cornfield DB, Papiez JS, Lynch J, Rimsza LM, Arch Pathol Lab Med, 6/1/2002
• Treatment of Refractory Acute Leukemia with Timed Sequential Chemotherapy using Topotecan followed by Motoxantrone + Etoposide (T-EM) and correlation with Topoisomeras...  
  Mainwaring M, Rimsza, L, Chen S, Gomez S, Weeks F, Lynch J. et. Al, Leukemia and Lymphoma, 1/1/2002
• Dose-Intense Ifosfamide/Doxorubicin/Cisplatin Based Chemotherapy for Osteosarcoma in Adults.  
  Patel S, Lynch JW, Johnson T, Carroll RR, Schuhmacher C, Spanier S, Scarborough M, American Journal of Clinical Oncology (CCT), 1/1/2002
• Join now to see all

Books/Book Chapters

• Hematology/Oncology Handbook 
  Chapter: Lymphomas 
  Lynch JWEditors: Leather H, George T.Edition 2nd ,2005
• Module 5: Preparing for End of Life; Caring for the Older Adult IV; CD-ROM and Internet Continuing Medical Information Course 
  Chapter: Breaking Bad News 
  Lynch JWUniversity of Florida Geriatric Education Center2004
• Hematology/Oncology Handbook 
  Leather H, Lynch J, Reddy S2002
• Regaining Compassion 
  Chapter: A Piece of My Mind 
  Lynch JWEditors: Roanne K. Young.JAMA & Archives Journals AMA2001
• Why Would a Loving God Allow Pain and Suffering in our lives? Patient education booklet 
  Page 1 - 54Lynch JW1999
• Current Radiation Oncology, Vol II 
  Page 1 - 31Mendenhall NP, Lynch JWEditors: Tobias.Edward Arnold, Publishers, London, England1995
• The non-Hodgkin’s Lymphomas 
  Chapter: Biologic Therapy for non-Hodgkin’s Lymphoma. 
  Lynch JWEditors: Tomas Kozak, M.D. Editor if chief..
• Join now to see all

Abstracts/Posters

• Including Patients in the Admission Process: A Pilot Project at UFCOM
  Lynch J, Amiri L, Madani S, and Fantone J., A Pilot Project at UFCOM; SGEA meeting, Savannah GA, 4/1/2013
• Impact of Age on Chemoradiation for Locally Advanced Non Small Cell Lung Cancer
  Jennifer L. Dallas1,2, MD; Jessica E. Sullivan1,2, DO; Charles E. Riggs, Jr1,2, MD; Wei Hou1, PhD; Kourtney D. LaPlant1,2, Pharm D; Thomas J. George, Jr1,2, MD; Paige ..., ASCO, 1/1/2010
• Prevention of Cetuximab Hypersensitivity Reactions and Post- Reaction Treatment.
  LaPlant KD, George TJ Jr., Walden E, Davis A, Riggs CR, Close JL, George SN, Lynch JW., GI ASCO, 1/1/2009
• Incidence of and Risk Factors for Cetuximab Hypersensitivity Reactions.
  George TJ Jr., LaPlant KD, Davis A, Walden E, Riggs CR, Close JL, George SN, Lynch JW, ASCO, 1/1/2009
• A Case of POEMS Syndrome with Leukopenia
  Nair J, Liu H and Lynch JW, ACP meeting, 5/1/2007
• Retrospective Review of Stage III Non-Small Cell Lung Cancer Patients Treated with Carboplatin/Paclitaxel plus Radiotherapy followed by Docetaxel.
  Patel MR, Weidner M, Walden E, Lynch JW, George TJ, ASCO, 1/1/2007
• Long term outcomes in Lymphocyte Predominant Hodgkin’s Disease
  Chera BS, Olivier K, Morris C, Lynch JW, Mendenhall NP, American Society of Therapeutic Radiology, 1/1/2006
• Comparison Between United States And Europe Of Enrollment Of Adult Patients In Published Lymphoma Clinical Trials
  Hagler KT, Lynch Jr, JW, Florida Joint Cancer Conference Fellows Forum, 2/1/2005
• Lymphomas with a Follicular Center Phenotype often contain large Tetraploid or near Tetraplioid B-Cells that are not in S-Phase despite High Ki-67 Expression.
  Al-Quran S, Li Y, Monreal M, Lynch J, Braylan R, Presented at the United States and Canadian Academy of Pathology meeting, 1/1/2003
• Prevalence of deep venous thrombosis (DVT) among oncology inpatients.
  Shea B, Patel S, Hellner L, Zumberg MS, Lynch JW, Wingard JR, Marshall J, Kao KJ., Blood, 1/1/2001
• Phase II individualized pharmacokinetic (PK) dosing of rituximab for patients with CD20 positive lymphoproliferative disorders.
  Lynch JW, Pusateri A, Balasubramanian L, Mendenhall N, Grow B., Blood, 1/1/2001
• Correlation of absolute lymphocyte count (ALC) on day +15 with length of stay in the bone marrow transplant unit, absolute neutrophil count (ANC) recovery, and CD34 ce...
  Gordan LN, Surgrue MW, Williams KD, Khan SA, Lynch JW, Wingard JR, Moreb JS., Blood, 1/1/2001
• Stimulation of In Vitro Endothelial Cell Proliferation by Acute Myeloid Leukemia Correlates with Poor Prognostic Features.
  Rimsza L, Ahrens k, Massey K, Lynch J, Braylan R, Blood, 1/1/2001
• Conditioned Media from CLL and SLL Stimulates In Vitro Endothelial Cell Proliferation and Decreases Endostatin Generation by Endothelial Cells, Both Likely Mediated by...
  Rimsza L, Pastos K, Lynch J, Braylan R, Blood, 1/1/2001
• Prognostic significance of expression of CD23 in a population of patients with morphologically atypical chronic lymphocytic leukemia.
  Larson B, Lynch JW, Hei D, Rimsza L, and Braylan R, ASH, 1/1/2000
• Autologous stem cell transplantation for lymphoma using stamp V conditioning regimen.
  Khan SA, Lynch JW, Boyett R, Reddy V, Finiewicz KJ, Zayden M, Miller A, Oblon D, Moreb JS, and Wingard JR, ASH, 1/1/2000
• Rituximab Use at Shands-University of Florida.
  Lanum SA, Lynch JW, Johnson ML, ASCO, 1/1/2000
• Zevalin Therapy Can Convert Peripheral Blood BCL-2 Status from Positive to Negative in Patients with Low-Grade, Follicular or Transformed Non-Hodgkin’s Lymphoma (NHL).
  Murray JL, Witzig TE, Wiseman GA, Czuczman MS, Lynch JW, Kornmehl E, Levy RL, Multani PS, Girllo-Lopez AJ, White CA, ASCO, 1/1/2000
• Phase II Study of timed sequential chemotherapy with Topotecan followed by mitoxantrone + etposide in the treatment of refractory leukemia and lymphoma.
  Mainwaring MG, Lynch JW, Reddy VJ, Rimsza L, Weeks F, Moreb J, Khan S, Crom D, Moore R, Belanger G, Wingard J, Blood supp., 1/1/1999
• Expression of IL-25 subunit (CD-25) in B cell NHL as determined by flow cytometry.
  Lynch JW, Rimsza L, Hei D, Douglas V. and Braylan R, Blood supp, 1/1/1999
• Topoisomerase II Levels and DNA Fragmentation in Leukemia Blasts treated with Topotecan followed by Etoposide + Mitoxantrone (T-EM) in a timed sequential chemotherapy ...
  Mainwaring MG, Lynch JW, Reddy VJ, Rimsza L, Braylan R, Rowe TC, Bradshaw K, Szostek J, and Wingard JR., Blood supp, 1/1/1999
• Rituximab Therapy of Lymphoproliferative Disorders in Immunosuppressed Patients. International Conference on Lymphoma
  Grillo-Lopez AJ, Lynch JW, Coieffier B, Connors J, Swinnen L. Venugopal, and Horning S, Ann Oncol, 1/1/1999
• Southern Society for Pediatric Research
  Piro l, White CA, Grillo-Lopez AJ, Janakiraman N, Beck TM, Shuey S, Czuczman M, Lynch JW, Kolitz JE, Jain V, Southern Society for Pediatric Research, 1/1/1999
• The Influence of Nodal Status on Outcome After High Dose Chemotherapy (HDC) Followed by Stem Cell Support in High Risk Breast Cancer Patients.
  Waples JM, Reddy S, Belanger G, Vellis K, Weeks F, Gian V, Moreb J, Eagle D, Lynch JW, Brouse G, Wingard JR., Blood supp, 11/1/1998
• Step Down Antibiotic Therapy For Febrile Neutropenia.
  Smith S, Wingard JR, Beltz S, Johnson M, Weeks F, Lynch JW, Ramphal R, Blood supp, 1/1/1998
• Join now to see all

Lectures

• Best Practices in Clinical Education: "Doc in the Box" — A Fourteen Year Success in Teaching Clinical Reasoning and Medical Decision Making 
  4/1/2012
• Review of PTCL 
  3/1/2010
• UF and Moffitt; HDAC 11 as a Novel Target in MCL 
  8/1/2009
• Student Reflections as Means to Restore the Human in the Medical Care of Human Beings: Seminar Series on the Eclipse and Reappearance of the Human in High Education 
  Christian Study Center of Gainesville - 10/1/2008
• Review of NHL for the Non-Oncologist 
  10/1/2008
• Mayo Clinic Review: Update in LGNHL 
  Ritz Carlton at Amelia Island - 8/1/2008
• Cancer Research at UF 
  7/1/2008
• Topics in Internal Medicine 
  3/1/2008
• Incorporating Reflection into a Clinical Clerkship 
  Chicago, IL - 9/1/2007
• The Students are Watching: Lessons Learned from Student Reflections 
  6/1/2007
• Incorporating Reflective Writing in the Internal Medicine Clerkship: Strategies, Pitfalls and Future Directions 
  Louisville, KY - 4/1/2007
• Low Grade NHL 
  Tampa FL - 3/1/2007
• Pharmacokinetics of Rituximab (Speaker) 
  3/1/2007
• NHL for the Generalist (Speaker) 
  2/1/2007
• Foundations of Professionalism; Do They Matter? (Speaker) 
  11/1/2006
• Review of Monoclonal Antibody Therapy for NHL 
  Lynchburg VA - 10/1/2006
• Grand Rounds: B-cell Malignancies 
  UAB School of Medicine at Montgomery - 8/1/2006
• Fellow Review of Lymphomas 
  Atlanta, GA - 6/1/2006
• The Faculty Calling 
  4/1/2006
• Treatment of LGNHL 
  Gainesville, GA - 3/1/2006
• Colloquium on Faith and Learning—Panelist 
  2/1/2006
• Treatment of NHL 
  South Bend - 11/1/2005
• Focus on Follicular Lymphoma 
  Baptist Hospital, Pensacola, FL - 10/1/2005
• Rituximab Therapy for the Treatment of Non-Hodgkin’s Lymphoma 
  Ponte Vedra Beach, FL - 10/1/2005
• Optimal Management of LGNHL 
  Mayo Clinic, Jacksonville - 4/1/2005
• Join now to see all